1. 1694PA phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results. (23rd October 2018) Authors: Lacouture, M; Dion, H; Ravipaty, S; Akmaev, V R; Sarangarajan, R; Jimenez, J J; Narain, N R; Berman, B; Goldfarb, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-014Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network study. (20th June 2018) Authors: Bekaii-Saab, T; Ou, F; Anderson, D; Ahn, D; Boland, P; Ciombor, K; Jacobs, N; Desnoyers, R; Cleary, J; Meyers, J; Chiorean, E; Pedersen, K; Barzi, A; Sloan, J; McCune, J; Lacouture, M; Lenz, H; Grothey, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P04.59 Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma. (19th September 2018) Authors: Lacouture, M; Hershkovich, H; Giladi, M; Blat, R; Bomzon, Z; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗